Understanding how hepatitis C virus affects the immune system using animal models

Animal Model to study heterogeneous outcomes of HCV Infection and Pathogenesis

NIH-funded research Research Inst Nationwide Children's Hosp · NIH-11097321

This study is looking at why some people with hepatitis C clear the virus while others end up with a long-lasting infection, using special animal models to learn more about how the immune system works in these different situations.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionResearch Inst Nationwide Children's Hosp NIH-funded
Lab location1 site (Columbus, United States)
Project IDNIH-11097321 on NIH RePORTER

What this research studies

This research investigates the different outcomes of hepatitis C virus (HCV) infections, focusing on why some individuals clear the virus while others develop chronic infections. By using specially adapted animal models, researchers aim to study the immune responses involved in these varying outcomes. The study involves isolating and adapting a rodent HCV-like virus to better understand the mechanisms of viral persistence and clearance. This approach will help identify the viral and immune factors that contribute to chronic infection and potential liver damage.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals infected with hepatitis C virus, particularly those who have developed chronic infections.

Not a fit: Patients who have successfully cleared the hepatitis C virus or those without any history of HCV infection may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and strategies for managing hepatitis C infections and preventing chronic disease.

How similar studies have performed: Previous research using animal models to study viral infections has shown promise, indicating that this approach could yield valuable insights into HCV pathogenesis.

Where this research is happening

Columbus, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.